$12.00
0.726.38%
At close: -
$12.00
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
MBX Biosciences Analyst Ratings and Price Targets | NASDAQ:MBX | Benzinga
MBX Biosciences Inc has a consensus price target of $37.4 based on the ratings of 5 analysts. The high is $44 issued by Guggenheim on April 10, 2025. The low is $30 issued by JP Morgan on October 8, 2024. The 3 most-recent analyst ratings were released by JMP Securities, Guggenheim, and Jefferies on April 10, 2025, April 10, 2025, and October 8, 2024, respectively. With an average price target of $39 between JMP Securities, Guggenheim, and Jefferies, there's an implied 225.00% upside for MBX Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Guggenheim
Jefferies
JP Morgan
Stifel
1calculated from analyst ratings
Analyst Ratings for MBX Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/10/2025 | Buy Now | 216.67% | JMP Securities | Jonathan Wolleben69% | → $38 | Initiates | → Market Outperform | Get Alert |
| 04/10/2025 | Buy Now | 266.67% | Guggenheim | Seamus Fernandez60% | $44 → $44 | Reiterates | Buy → Buy | Get Alert |
| 10/08/2024 | Buy Now | 191.67% | Jefferies | Michael Yee56% | → $35 | Initiates | → Buy | Get Alert |
| 10/08/2024 | Buy Now | 150% | JP Morgan | Jessica Fye67% | → $30 | Initiates | → Overweight | Get Alert |
| 10/08/2024 | Buy Now | 233.33% | Stifel | Annabel Samimy67% | → $40 | Initiates | → Buy | Get Alert |
| 10/08/2024 | Buy Now | 266.67% | Guggenheim | Seamus Fernandez60% | → $44 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for MBX Biosciences (MBX) stock?
The latest price target for MBX Biosciences (NASDAQ:MBX) was reported by JMP Securities on April 10, 2025. The analyst firm set a price target for $38.00 expecting MBX to rise to within 12 months (a possible 216.67% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MBX Biosciences (MBX)?
The latest analyst rating for MBX Biosciences (NASDAQ:MBX) was provided by JMP Securities, and MBX Biosciences initiated their market outperform rating.
When was the last upgrade for MBX Biosciences (MBX)?
There is no last upgrade for MBX Biosciences
When was the last downgrade for MBX Biosciences (MBX)?
There is no last downgrade for MBX Biosciences.
When is the next analyst rating going to be posted or updated for MBX Biosciences (MBX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MBX Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MBX Biosciences was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
Is the Analyst Rating MBX Biosciences (MBX) correct?
While ratings are subjective and will change, the latest MBX Biosciences (MBX) rating was a initiated with a price target of $0.00 to $38.00. The current price MBX Biosciences (MBX) is trading at is $12.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
